










Context. Metacognitive therapy and one of its treatment components, the attention 
training technique are increasingly being delivered to improve mental health. Objective. 
To examine the efficacy of metacognitive therapy and/or attention training technique on 
mental health outcomes from single-case studies. Methods. Fourteen studies (53 
patients) were included. The d-statistic for multiple baseline data and the percentage 
change index were used to compute the effect sizes. Results. Metacognitive therapy has 
a large effect on depression, anxiety, other psychopathological symptoms, and all 
outcomes together. Effect sizes were significantly moderated by the number of sessions, 
the severity and duration of symptoms, and patient gender, but not by study quality or 
attention training technique when used as a stand-alone treatment. At the follow-up, 
77.36% of the individuals were considered recovered or had maintained improvement. 
Conclusion. Metacognitive therapy and attention training technique strongly contribute 
to improving mental health outcomes. This study effectively informs evidence-based 
practice in the clinical milieu. 
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Metacognitive therapy was developed 2 decades ago to treat anxiety-related 
disorders, but has since been expanded as a general and transdiagnostic treatment 
approach (Wells, 2009). This therapy is based on the Self-Regulatory Executive 
Function model, a transdiagnostic and metacognitive model of emotional disorders. The 
model posits that the cause of many psychological disorders is rooted in the activation 
of a dysfunctional pattern of thinking and self-regulation called the “cognitive 
attentional syndrome”. More specifically, the cognitive attentional syndrome includes 
several features such as perseverative thinking (e.g., worry and rumination), threat 
monitoring, and counterproductive cognitive-behavioral coping strategies such as 
thought control and suppression, reassurance seeking, emotional avoidance, or 
substance use (Wells, 2009). These dysfunctional coping strategies in particular 
contribute to dysregulation and the maintenance of negative beliefs and emotional 
distress. Although the cognitive attentional syndrome aims to deal with negative 
thoughts, beliefs, or emotions, it prevents these experiences from being efficiently 
regulated. In addition, the excessive conceptual processing underlying the cognitive 
attentional syndrome is fueled by diminished attentional control and, in particular, 
marked difficulty in disengaging from rumination, worry, and other forms of self-
focused attention. 
According to the Self-Regulatory Executive Function model, the cognitive 
attentional syndrome results from positive and negative dysfunctional metacognitive 
beliefs (Wells, 2009). On the one hand, positive metacognitive beliefs refer to the 
usefulness of rumination, worry, rituals, threat monitoring, and other similar strategies 
(e.g., “I must worry in order to face daily life problems”; “I must control my thoughts or 
something bad will happen”). On the other hand, negative metacognitive beliefs refer to 
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the negative implications and meaning attributed to mental processes such as thoughts 
or mental images (e.g., “Some thoughts are dangerous or harmful”; “Intrusive images 
are a sign of folly”). Although it is predominantly the case that negative metacognitive 
beliefs are the most significant causal influence on pathology, the co-occurrence of 
positive and negative metacognitive beliefs can be detrimental as well (Wells, 2009). 
 In recent years, accumulating evidence corroborates the Self-Regulatory 
Executive Function model by showing that dysfunctional metacognitive beliefs play a 
pivotal role in the etiology of numerous mental disorders (Sun, Zhu, & So, 2017). 
Rather than challenging the validity of thoughts and beliefs about the self, others, 
and the world, as in traditional cognitive-behavioral therapy, metacognitive therapy 
fosters the development of a detached awareness vis-à-vis one’s thoughts and aims at 
optimizing the control of dysfunctional cognitive emotion regulation strategies (e.g., 
worry, rumination) and maladaptive attentional strategies. Crucially, in contrast to 
cognitive-behavioral therapy, metacognitive therapy focuses on the process rather than 
the content of thinking. Indeed, it aims at interrupting the cognitive attentional 
syndrome triggered by negative thoughts by favoring a detached mindful state, 
improving attentional flexibility, and strengthening executive control. Ultimately, such a 
shift in the process of treating internal and external information is supposed to challenge 
both the positive and the negative metacognitive beliefs that perpetuate emotional 
distress. Typically, metacognitive therapy lasts for approximately 12 sessions and 
begins with the identification of the cognitive attentional syndrome through an 
idiosyncratic case formulation derived from both evidence-based, disorder-specific 




Specific intervention techniques have been developed within the framework of 
metacognitive therapy to optimize and facilitate effective executive control and to 
mitigate the cognitive attentional syndrome ; such techniques include attention training 
technique, detached mindfulness, and worry and rumination postponement (Wells, 
2009). In particular, the efficacy of attention training technique as a stand-alone 
intervention has been investigated in a growing number of studies (for a review, see 
Fergus & Bardeen, 2016). During attention training technique sessions, participants are 
first provided with a rationale explaining that this technique has to be considered a 
strategy that aims to decrease self-focused attention. Regarding logistics, a series of 
close and distant environmental sounds (e.g., the voice of the therapist, a tapping on a 
table, the sound of water drops falling on a washbasin, the distant sound of traffic) are 
typically used in the framework of guided exercises that aim to recruit various 
attentional process involved in the improvement of cognitive control. The number of 
sounds used can vary providing the task is sufficiently difficult to tax attentional 
resources. In general, the clinician gives verbal instructions as to how patients should 
attend to auditory stimuli. However, an automated version (audio recording) has also 
been developed (Fergus & Bardeen, 2016). 
According to Wells (2009), a typical attention training technique session 
comprises three types of exercises that successively require (1) selective attention (i.e., 
focusing on one specific sound after another), (2) rapid attention switching (i.e., rapidly 
switching from one sound to another), and (3) divided attention (i.e., deploying attention 
to all of the sounds simultaneously). The entire procedure lasts approximately 12 min. 
In accordance with Wells’ (2009) procedure, patients are told that attention training 
technique must not be viewed and used as a coping strategy deployed to become 
distracted or to avoid negative thoughts or emotions, nor to control their negative 
6 
 
thoughts and emotions. From such a perspective, all intrusive thoughts or feelings that 
occur while performing the exercises may be noticed incidentally, and if so they should 
be treated as “background noise”. Consequently, participants are clearly instructed not 
to deal with them, but rather to consider them as opportunities to improve attentional 
control. Each session ends with a collaborative review of the exercises, and then 
participants are instructed to practice attention training technique at home daily.  
The reason for why the attention-training technique has been singled-out as a 
stand-alone intervention lies in the fact that it specifically targets excessive and 
inflexible self-focused attention, which constitutes a key process underlying many 
psychopathological states. Indeed, the rationale behind the technique is that the auditory 
monitoring exercises performed in the attention training technique are cognitively 
demanding enough to recruit and improve attentional control, interrupting the cognitive 
attentional syndrome (and the focus on self-focused repetitive thinking or threat 
monitoring) via the processing of external non-self-relevant stimuli (Knowles, Foden, 
El-Deredy, & Wells, 2016). 
Although metacognitive therapy share common features with other psychological 
process-centered interventions, such as mindfulness-based interventions, it also differs 
from them. For instance, both attention training technique and mindfulness-based 
interventions aim at regulating the focus of attention, detached mindfulness in 
metacognitive therapy does not involve meditation or body-focused exercises and rather 
aims at developing meta-awareness of thoughts than present-to-moment awareness 
(Wells, 2009). 
The efficacy of metacognitive therapy has been examined in a range of 
randomized controlled trials conducted in clinical samples. More specifically, a recent 
meta-analysis performed by Normann, van Emmerik, and Morina (2014) that 
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incorporated 16 studies conducted on 384 outpatients with mental disorders (including 
OCD, PTSD, GAD, major depressive disorder, postpartum depression, or comorbid 
anxious and mood disorders) showed a large effect size on the primary outcome 
measures (Hedges’ g of 2.00 for within group pre- to posttreatment and 1.65 for within 
group pretreatment to follow-up). Of note, nine studies included in this meta-analysis 
were controlled trials, and seven were uncontrolled trials (with four open trials and three 
single-case designs). An important finding from this meta-analysis was that it supported 
the conclusion that metacognitive therapy is superior to both a control condition 
(waiting list) and a traditional cognitive-behavior treatment. The latter result must, 
however, be taken cautiously, given the small number of studies included (Normann et 
al., 2014). Notably, the meta-analysis showed not only that metacognitive therapy 
decreased symptoms related to patients’ primary diagnosis, but also that it mitigated 
transdiagnostic processes, such as the dysfunctional metacognitive beliefs related to the 
cognitive attentional syndrome. This result in particular strengthens the feature of the 
Self-Regulatory Executive Function model that considers a common underlying harmful 
style of thinking to contribute to psychological distress across disorders (Wells, 2009). 
Overall, it appears that a convincing corpus of data supports metacognitive therapy as 
an effective approach to treat emotional disorders. 
 
While this recent meta-analytic review of metacognitive therapy demonstrated large 
effect sizes across anxiety disorders and depression (Normann et al., 2014), the efficacy 
of the attention training technique as a stand-alone intervention has also been 
systematically assessed, with numerous studies demonstrating that it is efficacious 
across a number of psychopathological conditions (Fergus & Bardeen, 2016). Attention 
training technique might be relevant as a stand-alone intervention because it particularly 
targets excessive and inflexible self-focused attention underlying worry, rumination, 
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and threat monitoring that characterizes the cognitive attentional syndrome. More 
specifically, Knowles et al. (2016) recently performed a meta-analysis of both single-
case and group studies on eight articles (four single cases and four randomized 
controlled trials) comprising 293 participants. Single-case outcomes indicated that 
attention training technique yields large effect size estimates, expressed as improvement 
rate difference, with a pooled effect size ranging from 0.74 to 1.00 for anxiety and 
depressive disorders. In addition, standardized effect size across the four randomized 
controlled trials indicated that attention training technique is more efficacious (with a 
small-to-large effect size depending on the outcome) than control groups in relation to 
various outcomes (e.g., intrusive thoughts, self-focused attention, attention flexibility, 
pain threshold, hypervigilance). Long-term effects (from 6 to 12 months) were also 
reported in most of the studies considered for the analyses. 
Numerous studies have provided empirical evidence for the efficacy of 
metacognitive therapy or attention training technique as a stand-alone intervention, but 
no meta-analysis has to date been performed to examine the efficacy of metacognitive 
therapy in single-case studies, although an important number of single-case design 
studies on metacognitive therapy have been published in the last 2 decades. Single-case 
methodology has unique strengths for assessing the efficacy of a treatment and thus 
constitutes a clinically relevant and scientifically well-established alternative to 
traditional group comparison designs (e.g., Dattilio, 2006). The scientific rigor of 
single-case methodology has also been acknowledged by influential international 
groups in the evidence-based movement (OCEBM Levels of Evidence Working Group, 
2011). In addition, encouraged by the evidenced-based practice movement, researchers 
have adapted (or developed) methodology and statistical analyses to single-case design 
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and these techniques have progressed in recent years (e.g., Manolov, Gast, Perdices, & 
Evans, 2014). 
The primary aim of this meta-analysis was to estimate the effect of metacognitive 
therapy on mental health in single-case studies exclusively. The analyses focused on 
various mental health outcomes considered together or separately so that the results of 
the present study could be directly compared to those of previous systematic reviews of 
group designs on this topic (Normann et al., 2014; Sadeghi, Mokhber, Mahmoudi, 
Asgharipour, & Seyfi, 2015). For this purpose, we used a data analysis procedure 
specifically developed on the basis of statistical theory for single-case design outcomes 
so that they would be comparable to traditional group-design outcomes (Shadish, 
Hedges, & Pustejovsky, 2014). The second objective was to compare the efficacy of one 
specific component of metacognitive therapy, the attention training technique, as a 
stand-alone treatment, to the efficacy of metacognitive therapy as a whole package 
treatment program by including a moderator variable specifying whether attention 
training technique was or was not used as a stand-alone treatment. This question is 
particularly relevant because attention training technique is considered a low-cost, easy-
to-administer technique that provides an economic advantage compared with the full-
package therapeutic program (Fergus & Bardeen, 2016). The third objective was to 
examine the effect of specific moderators (e.g., sociodemographic variables, number of 
sessions, duration of symptoms, presence of comorbidity, psychotropic medication use, 
severity of the target behavior at baseline) on the outcomes to better understand for 
whom metacognitive therapy produced the greatest effect, thereby reinforcing evidence-





This study was conducted in accordance with the preferred reporting items for 
systematic reviews and meta-analyses that evaluate health care interventions (PRISMA; 
Moher et al., 2009). 
Search strategy 
A systematic literature search was conducted in three electronic databases: PsycINFO, 
PubMed, and Web of Science. Each database was initially searched for English 
language journal articles from the first available date until January 2, 2017, using the 
following search terms: (metacognitive therapy OR attention training technique) AND 
(single-case OR case series OR multiple baseline OR case study).  
The search was also supplemented with the following steps: (a) authors who had 
published substantially in the area were contacted to obtain information about published 
or unpublished articles germane to the review, (b) Google Scholar was used to search 
for articles that may have been unidentified, and (c) reference sections of identified 
articles, in particular systematic reviews and meta-analyses on the topic (e.g., Fergus & 
Bardeen, 2016; Knowles et al., 2016; Normann et al., 2014; Sadeghi et al., 2015), were 
examined and a citation search was conducted to identify further studies. 
Selection of studies 
After the removal of duplicates, the remaining titles were reviewed and the abstracts of 
the potentially relevant articles screened. The full texts of the selected articles were then 
obtained and assessed for eligibility. The screening of titles, abstracts, and full-text 
articles was independently conducted by two authors (LR, JB). Disagreements between 
the authors were discussed until consensus was reached.  
11 
 
Figure 1 shows the search process in detail. The initial results identified 70 
citations after de-duplication, which were then examined against the following inclusion 
criteria:  
- Studies had to evaluate the effectiveness of metacognitive therapy or attention training 
technique as a stand-alone intervention.  
- Studies had to be published in English only and in peer-reviewed journals.  
- Studies had to use a single-case methodology in which the design had to include a 
series of discrete phases wherein an intervention was manipulated in an experimentally 
controlled manner (i.e., was systematically applied and withdrawn) and the target 
behavior was continuously and frequently measured (Tate et al., 2015). Single-case 
studies that used appropriate methodology to rule out threats to internal validity such as 
a single-case experimental design (e.g., reversal, multiple baseline, alternating 
treatments) were acceptable for inclusion. Furthermore, quasi-experimental designs 
(e.g., AB with maintenance phase) were included if they relied on validated 
psychopathology measures.  
- Studies had to examine clinical adult samples with a formal diagnosis and/or who met 
criteria on a validated psychopathology measure.  
- Studies had to use health-related outcome measures of psychopathology or symptom 
severity, or measures of cognitive modification related to the targeted psychopathology.  
We excluded studies that (a) did not include any comparisons with at least three 
measurement points per phase of the intervention, because this is both a design 
requirement (Kratochwill et al., 2010) and a necessity for the statistical analyses; (b) 
were only descriptive; or (c) used a pre/post design, as this is not considered stricto 
sensu single-case methodology (Tate et al., 2015). 
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A total of 14 articles met full inclusion criteria, for which full paper copies were 
retrieved to assess further eligibility. 
Data extraction and quality assessment 
For each included study, the following data were extracted by the first author (LR) 
and then checked by the third author (JB): year of publication, number of patients 
included, type of diagnosis or targeted psychopathology, type of intervention and 
number of sessions, outcomes considered, and type of single-case design adopted (Table 
1). For each participant of each included study, moderators were then extracted by the 
first author (LR) and further checked by the third author (JB): age, gender, number of 
sessions, presence versus absence of comorbid psychopathology, presence versus 
absence of psychotropic medication, duration of symptoms, and severity of symptoms at 
baseline. In addition, studies that examined the efficacy of attention training technique 
as a stand-alone treatment were distinguished from those that used a more 
comprehensive metacognitive therapy treatment approach. Raw data for the outcomes 
measured were extracted from the graphs by the second author (RM) with PlotDigitizer 
2.6.3 for Windows (plotdigitizer.sourceforge.net/). Previous research has shown that 
data retrieval from graphs leads to reliable and valid results across several data 
extraction software tools (Drevon, Fursa, & Malcolm, 2017). 
The methodological quality of each study was independently assessed by two 
authors (LR, RM), who used the 15 criteria of the Risk of Bias in N-of-1 Trials 
(RoBiNT) Scale (Tate et al., 2015), which assesses internal and external validity of each 
study by assigning 2 points for each criteria that is fully met, 1 point if partially met, 
and 0 points if not met. Thus, the maximum score is 30 points. Disagreements between 
the two authors who assessed the quality of the studies were discussed until an 
agreement was reached.  
13 
 
Three corresponding authors of four different studies were contacted because 
insufficient information was provided in the article regarding data extraction, or to make 
an accurate quality assessment. One author provided supplementary information.  
Data analysis 
Choice of meta-analytic strategy 
The between-case standardized mean difference, more widely known as the d-
statistic, was chosen because it allows for a classical meta-analysis using inverse 
variance weighting, representing the effects via a forest plot. The main limitations of d-
statistic are detailed in Valentine, Tanner-Smith, Pustejovsky and Lau (2016). One of 
the restrictions regards its applicability to studies with at least three participants, which 
was the case for 7 of the 9 studies reporting anxiety (77.78%) and 9 of the 10 studies 
reporting depression outcomes (90.00%). These values indicate that the loss of 
information due to the use of d-statistic was relatively minor. Additionally, the 
percentage change index (Hershberger, Wallace, Green, & Marquis, 1999) is computed 
for all two-phase comparisons between an A (baseline) phase and a subsequent B 
(intervention) phase for all participants. The use of the percentage change index is well-
aligned with the visual inspection of the data suggesting that there was a progressive 
improvement (i.e., a change in slope) in many of the data sets, given that it focuses on 
the last three measurements per phase. 
Calculation of effect sizes 
Meta-analyses were performed grouping the outcomes in four different ways: (a) 
outcomes referring to anxiety using the Beck Anxiety Inventory (Beck, Epstein, Brown, 
& Steer, 1988) and the Hospital Anxiety and Depression Scale (Zigmon & Snaith, 
1983); (b) outcomes referring to depression using the Beck Depression Inventory (Beck, 
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Ward, Mendelson, Mock, & Erbaugh, 1961), Hospital Anxiety and Depression Scale 
and the Geriatric Depression Scale (Yesavage et al., 1982); (c) other psychopathological 
outcomes (labelled as “remaining” hereinafter). Note that in the study by McNicol, 
Salmon, Young, and Fisher (2013), only the total score of the Hospital Anxiety and 
Depression scale is used and thus the outcome was labeled as “remaining”, as it did not 
refer to either depression or anxiety separately; (d) all outcomes (anxiety, depression, 
and the remaining ones) grouped together. In all cases, improvement is seen as a 
reduction in the measurements.  
When meta-analyzing with the d-statistic, one effect size per study is obtained, as 
this index combines the results for several participants into a single quantification. The 
data from Wells (1990) and McNicol et al. (2013) were not taken into account as they 
include only one participant and the data from Wells et al. (1997) because they include 
only two participants. Additionally, Papageorgiou and Wells (2000) measured outcomes 
only related to depression and anxiety and, thus, this study was not included for the 
meta-analysis of the remaining outcomes. For the d-statistic, the analyses for each study 
were performed using the “scdhlm” (https://github.com/jepusto/scdhlm) package for R 
(R Core Team, 2015), also available at https://jepusto.shinyapps.io/scdhlm/, whereas 
meta-analysis was performed using random effects models via the R code presented in 
Manolov and Solanas (2016). 
For the percentage change index, we computed one value for each AB comparison 
and then obtained an average percentage change index per study and per outcome 
(anxiety, depression, remaining, or all), using the number of measurements in the AB 
comparison as a weight. The meta-analysis of these one-per-study average percentage 
change index values was performed using the number of measurements available in the 
study as a weight, a reasonable approach according to Kratochwill et al. (2010), when 
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inverse variance weighting is impossible. The meta-analysis using the percentage 
change index was performed via the R code from Manolov and Rochat (2015).  
Vote counting 
Vote-counting was applied to the follow up data. That is, we tallied the number of 
follow-up results that the authors considered as positive (effective intervention), 
focusing on the most stringent of all the criteria reported by the primary authors and on 
the latest follow-up measure available. After the number of positive results was tallied, 
the proportion of positive results in relation to the total number of participants was 
compared to the chance proportion of 0.5 using the binomial test; we also constructed 
the confidence interval around the proportion observed via the expressions provided in 
Bushman and Wang (2009).  
Assessment of the evidence for metacognitive therapy 
We assessed whether metacognitive therapy can be considered an “evidence-based 
practice” via the 5-3-20 criterion (Kratochwill et al., 2013) requiring positive evidence 
for the intervention from at least 5 studies carried out by three different and independent 
research teams and including at least 20 participants.  
Moderator analysis 
We considered moderator analysis to be justified when significant results of the Q test 
for heterogeneity of effects were obtained and for I2 values greater than 50% (medium 
relative heterogeneity) and especially for I2>75% (large relative heterogeneity). We 
used the following moderator variables: Metacognitive therapy vs attention training 
technique as a standalone treatment, the mean level of the target behavior during 
baseline, the number of intervention sessions, the duration of the disease in months, 
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whether participants were taking or not psychotropic medication when the study was 
carried out, the age and gender of the participants, and the presence or absence of co-
morbidity. A file with all the moderators by participants and studies is provided at 
https://osf.io/am77z/. 
In order to perform moderator analyses for the d-statistic at the study level, as 
described by Shadish et al. (2014), a single quantification per study for each moderator 
has to be obtained. Therefore, we calculated the proportion of individuals displaying a 
comorbid psychopathology, taking psychotropic medication and being female and 
computed the average age, duration of symptoms, and the number of sessions during the 
intervention phase. In order to examine the importance of the moderator variables at the 
individual level, we used the moderators in simple linear regression analyses, weighted 
by the number of measurements in phases being compared, one per each moderator used 
as a predictor of the values of the percentage change index computed for outcomes 
related to anxiety and depression.  
Assessment of publication bias 
Publication bias was dealt with in three ways. First, a funnel plot was created by 
plotting the effect sizes on the abscissa and the standard error of the effect size index on 
the ordinate. Publication bias is usually inferred from a lack of symmetry in the 
distribution of effect sizes, with smaller studies providing only larger effects (Sterne, 
Egger, & Moher, 2008). Second, to counter the potential subjectivity of the funnel plot, 
we used Egger’s regression test (Egger, Smith, Schneider, & Minder, 1997) for 
exploring whether the effect size of smaller studies differs systematically from the effect 
size found in larger studies using a nominal alpha of 0.10 (i.e., rejecting the null 
hypothesis if p ≤ 0.10) instead of the common 0.05, as suggested by Egger et al. (1997) 
for meta-analyses including relatively few studies. Third, Duval and Tweedie's (2000) 
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trim-and-fill procedure was applied, which eliminates any existing asymmetric effect 
sizes to estimate the center of the funnel plot (i.e., the overall summary measure), 
replaces these asymmetric effect sizes and their symmetric counterparts and re-estimates 
the average and the variance of the summary measure. Therefore, an adjusted effect size 





Selection of studies 
A flow diagram of the study selection process is presented in Figure 1. The electronic 
database searches produced 70 records after removal of duplicates. After reviewing the 
titles and the abstract, we identified 22 potentially eligible records. Full-text versions of 
these articles were obtained and assessed for eligibility. This led to the inclusion of 14 
single-case studies that compared metacognitive therapy or attention training technique 
as a stand-alone treatment to a baseline in a total of 52 participants (53 if counting a 
participant in the study by Fitt & Rees, 2012, who did not complete the intervention). 
Unpublished data were not identified.  
--INSERT FIGURE 1 HERE-- 
Description of included studies 
Characteristics of the included trials are presented in Table 1. 
 
--INSERT TABLE 1 HERE-- 
Sample characteristics 
The total sample comprised 53 outpatients, of whom 10 received attention training 
technique as a stand-alone treatment. Three participants were excluded because not 
enough data points (i.e., fewer than 3 per phase) were collected and one participant was 
excluded because of not completing the intervention (Fitt & Rees, 2012). The majority 
of the sample was female (80%). All participants were adults, with ages ranging from 
20 to 71 years. The total sample size per study ranged from one to six patients. Eight of 
the 14 studies were conducted in patients with a primary diagnosis of anxiety disorder 
(OCD, panic, hypochondriasis), four in patients with depression (postpartum, recurrent 
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major depressive disorder, major depressive episode), one patient with paranoid 
schizophrenia, and one in a patient who was a cancer survivor with emotional distress 
(anxiety, depression, PTSD). The mean duration of symptoms was 95.19 months (range 
from 2 to 480 months). Twenty-two patients had a least one comorbidity and 19 had a 
concurrent psychotropic medication at the time of the intervention. 
Intervention characteristics 
Most studies examined the efficacy of metacognitive therapy by using the original 
manual developed by Wells (2009), whereas two studies (Bevan et al., 2013; Hutton, 
Morrison, Wardle, & Wells, 2014) adapted the intervention to a specific target 
population (postpartum depression and paranoid schizophrenia, respectively). In 
addition, four studies examined the efficacy of attention training technique as a stand-
alone treatment. All interventions were conducted face to face (one patient, one 
practitioner) and one intervention was delivered by video conference (Fitt & Rees, 
2012). Sessions were usually delivered on a weekly basis and the total number ranged 
from 4 to 14.  
Design 
Among the 14 studies, three used a single-case experimental design (e.g., multiple 
baseline across participants, reversal design) in that the structure of the design provided 
sufficient opportunity to adequately demonstrate the experimental effect (Andouz, 
Dolatshahi, Moshtagh, & Dadkhah, 2012; Wells, 1990; Wells et al., 1997). The 
remaining studies used a quasi-experimental design such as an AB design, which is not 
considered experimental in that it does not provide an added opportunity to demonstrate 




Outcome measures (an index of all outcomes is reported in Table 1) were 
administered as follows: depression in 30 comparisons, anxiety in 34 comparisons, 
remaining outcomes in 103 comparisons. All instruments had good psychometric 
properties. All studies provided at least one follow-up session ranging from 6 weeks to 
41 months. 
Methodological quality 
The quality assessment scores ranged from 8 to 15 points on the RoBiNT scale 
(see Table 1). All studies fully met the criteria of raw data record and full description of 
the dependent variables, both criteria referring to external validity. Criteria referring to 
internal validity were the most poorly rated. Interrater agreement on the quality 
assessment was elevated (94%). Note that the RoBiNT Scale represents stringent 
standards (Tate et al., 2015) and was initially published in 2013, the same year as two of 
the studies included here and only prior to the publication of three of the 14 studies from 
the current meta-analysis.  
Meta-analysis 
d-statistic 
The numerical results of the meta-analysis with the d-statistic can be consulted in 
Table 2. The effect sizes per study and the overall average, including confidence 
intervals, are represented in Figure 2 (for anxiety) and in Figure 3 (for depression). The 
forest plots for the remaining outcomes and for all outcomes considered together can be 
obtained from https://osf.io/am77z/. The values of the d-statistic indicate that in all 
studies (and consequently for all overall summary measures), the effect of the 
intervention has been in the desired direction. All four summary measures, most of the 
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effects per study, and the overall weighted average effect size could be labeled as 
“large” according to Cohen’s (1992) criteria (i.e., greater than 0.8).1  
--INSERT TABLE 2 ABOUT HERE-- 
--INSERT FIGURES 2 AND 3 ABOUT HERE-- 
Percentage change index  
Regarding the results of using the percentage change index, for all studies, the results 
for all participants, except for one participant in Hutton et al. (2014), indicate a 
reduction in the problematic behaviors/outcomes measured. The average reduction is 
approximately 60-68% and for very few studies, the averages are below 50%. Graphical 
representations of the results for the percentage change index are available from 
https://osf.io/am77z/.Therefore, metacognitive therapy is apparently effective, given the 
large reductions observed on three levels: individually, on average per study, and in 
terms of the overall weighted average for all studies.  
Vote counting 
The results for vote counting indicates that 41 of the 53 individuals (77.36%) 
maintained the improvement achieved during the intervention phase at the most 
stringent criteria for intervention effectiveness and at the longest available follow-up 
point (ranging from 6 weeks to 41 months). This percentage was statistically 
significantly different from 0.5 according to the binomial test (p < .01), and the 
                                                          
1 The use of Cohen’s benchmarks for single-case designs has been put in doubt (Parker et al., 2005) and 
Harrington and Velicer (2015) suggested referring to values between 1 and 2.5 as “medium effects.” 
However, they used the within-case version and not the d-statistic created to be comparable to that 
obtainable from between-group designs (Hedges, Pustejovsky, & Shadish, 2013).  
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confidence interval for the percentage estimated according to the formulas from 
Bushman and Wang (2009) ranged between 0.707 and 0.804. Notably, for this analysis, 
the two participants for whom there were fewer than three baseline phase measurements 
were taken into account (Fitt & Rees, 2012; Wells et al., 1997), as was the participant 
who did not complete the intervention in Fitt and Rees’ (2012) study. 
Assessment of the evidence for metacognitive therapy 
Considering the results represented in the forest plots and the number of 
participants with positive results at follow-up, the minimum of 20 individuals who 
benefitted from metacognitive therapy or attention training technique is achieved. 
Additionally, given that 14 studies are included in the current meta-analysis, the 
minimum of five studies is also met for all outcomes considered together. Regarding the 
need for these studies to be authored by at “least three research teams with no 
overlapping authorship at three different institutions” (Kratochwill et al., 2013, p. 33), 
this criterion is met.   
Apart from these general conclusions, according to the percentage change index 
computed for depression, metacognitive therapy always leads to reduction of scores, 
specifically for 42 participants in 10 studies and three different research teams (Andouz 
et al., 2012; Fitt & Rees, 2012; and eight studies in which Adrian Wells contributed 
[Bevan et al., 2013; Callesen, Jensen, & Wells, 2014; Fisher & Wells, 2008; Hutton et 
al., 2014; Papageorgiou & Wells, 1998, 2000; Wells & Sembi, 2004; Wells et al., 
2009]; and Andouz et al., 2012; Fitt & Rees, 2012, and eight studies in which Adrian 
Wells contributed [Bevan et al., 2013; Callesen et al., 2014; Fisher & Wells, 2008; 
Hutton et al., 2014; Papageorgiou & Wells, 1998, 2000; Wells & Sembi, 2004; Wells et 
al., 1997]). According to the percentage change index computed for anxiety, 
metacognitive therapy always leads to reduction of the scores, specifically for a total of 
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33 participants in 9 studies and two different research teams (Fitt & Rees, 2012, and 
eight studies in which Adrian Wells participated [Bailey & Wells, 2014; Bevan et al., 
2013; Fisher & Wells, 2008; Hutton et al., 2014; Papageorgiou & Wells, 1998, 2000; 
Wells & Sembi, 2004; Wells et al., 1997]). Therefore, given that the “5-3-20 rule” is 
met considering all outcomes together, as well as for depression, there appears to be 
enough empirical support to refer to metacognitive therapy as an evidence-based 
practice.  
Moderator analysis at the study level using the d-statistic 
Heterogeneity descriptive statistics and the Q test results for heterogeneity are 
presented in Table 2. The Q test suggested that there is statistically significant 
heterogeneity in the effect sizes across the studies for all outcomes considered together, 
for depression, and for the remaining outcomes. Moreover, the proportion of 
heterogeneity that is due to the variation in true effects, rather than being sampling 
error, is large (i.e., I2 > 75%) for all outcomes and for the remaining outcomes and 
medium (I2 ≈ 50%) for depression. Following the suggestion by Borenstein, Hedges, 
Higgins and Rothstein (2009), we also report τ, the standard deviation of the true 
effects, with values between 0.51 and 0.65 for all outcomes, depression, and remaining 
outcomes (apart from anxiety and depression), which are apparently large considering 
that the weighted average d-statistic values are between −1.72 and −1.20 for these 
outcomes. The range of d-statistics for the individual studies is also wide, although for 
depression, the range is affected by the extreme d-statistic value for the Papageorgiou 
and Wells (2000) study and for anxiety, it is affected by the extreme d-statistic value for 
the Papageorgiou and Wells (1998) study. 
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For all outcomes considered together, the number of sessions was statistically 
significantly related to the effect sizes (p = .044; R2 = 45.64%) and this reduced I2 from 
81.02% to 68.11%, with more sessions being associated with larger differences between 
baseline and intervention conditions. The proportion of female participants in the 
sample was also statistically significantly related to the effect sizes (p = .031; 
R2=54.79%) and this reduced I2 from 81.02% to 62.50%, with studies with fewer female 
participants reporting greater differences between intervention and baseline. The two 
moderators are collinear (r = −.61, p = .059) and thus were not used jointly in the same 
model.  
Finally, for depression as outcome, none of the moderators was statistically 
significantly related to the effect sizes and the moderator that reduced I2 to a greater 
extent (from 55.94 to 49.93%) was the number of sessions, with more sessions being 
associated with larger differences between baseline and intervention conditions. For the 
remaining outcomes, none of the moderators was statistically significantly related to the 
effect sizes and the moderator that reduced I2 to a greater extent (from 76.73% to 
68.26%) was the proportion of female participants, with studies with fewer female 
participants reporting greater differences between intervention and baseline. 
Moderator analysis at the individual level using the percentage change index 
For anxiety, the average of the last three baseline measurements was statistically 
significantly related to the percentage change index values (b = 1.15, p = .001, R2 = 
32.91%). More specifically, lower baseline levels of anxiety were related to a greater 
decrease in symptoms. For depression, the duration of the symptoms was statistically 
significantly related to the percentage change index values (b = 0.045, p = .039, R2= 
11.95%), indicating that longer symptom duration was associated with worse results. 
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Similar to those for anxiety, lower baseline levels of depression were related to greater 
reductions (b = 0.62, R2 = 9.70%), but this result was not statistically significant (p = 
.077). When the duration of the symptoms and the baseline level of depression were 
used as predictors in a multiple regression, these variables accounted for R2 = 22.83% of 
the variability in the percentage change index values (p = .020 for the model).  
Assessment of publication bias 
The result of the funnel plots for the d-statistic are available from 
https://osf.io/am77z/. The distributions are practically symmetric, with one outlier for 
both anxiety and depression. Therefore, visually, there seems to be one extreme result 
included rather than solid evidence for publication bias for anxiety and depression. If 
the meta-analytic summary for anxiety is performed without the Papageorgiou and 
Wells (1998) study, the overall d is −1.31 (instead of −1.41) with a confidence interval 
ranging between −1.76 and −0.86. If the meta-analytic summary for depression is 
performed without the Papageorgiou and Wells (2000) study, the overall d is −1.08 
(instead of −1.20) with a confidence interval ranging between −1.58 and −0.57. Thus, 
the conclusions do not change substantially after removing extreme values. More 
asymmetric results are apparently present when considering the remaining outcomes or 
all outcomes together.  
In order not to rely on visual inspection only, we used Egger’s regression test for 
funnel plot asymmetry. The following results were obtained: (a) for all outcomes, Z = 
−1.53, p = .13; (b) for anxiety, Z = −1.12, p = .26; (c) for depression, Z = −2.21, p = .03; 
and (d) for the remaining outcomes, Z = −0.80, p = .43. Therefore, statistically, there is 
an indication of asymmetry and potential publication bias for depression only. 
Nevertheless, we still applied the trim-and-fill method to obtain adjusted overall means 
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supposed to be free of publication bias. These means (for all outcomes −1.29 instead of 
−1.55, with a confidence interval ranging between −1.72 and −0.85; for the remaining 
outcomes, −1.45 instead of −1.72, with a confidence interval ranging between −1.98 
and −0.92) continue indicating that a relatively large reduction of problematic outcomes 
has taken place.  
Discussion 
The main aim of this meta-analysis was to estimate the overall effects of metacognitive 
therapy on mental health outcomes in single-case studies. We used specific and 
appropriate analyses developed on the basis of statistical theory for single-case design 
outcomes so that they would be comparable to group-design outcomes, and the results 
indicated that metacognitive therapy has a large effect size on anxiety, depression, other 
psychopathological symptoms, and all outcomes considered together. Publication bias 
was statistically detected only for depression as outcome, probably due to one outlying 
effect size. However, we verified that the overall result (a large effect of meta-cognitive 
therapy) did not change substantially in either of two re-analyses: (a) when removing 
the outlying value from the meta-analysis; and (b) when obtaining an adjusted summary 
measure, imputing potentially missing effect sizes, according to the trim-and-fill 
method. Additional analyses revealed that effect sizes were moderated by the number of 
intervention sessions, the severity and duration of symptoms, and patient gender, but not 
by study quality or the type of intervention (i.e., attention training technique as a stand-
alone treatment vs. the whole metacognitive therapy package).  
Together, these results support the use of metacognitive therapy or attention 
training technique, as an evidence-based intervention to treat emotional disorders. This 
result corroborates previous meta-analyses conducted on group designs that showed a 
medium to large effect on mental health outcomes of metacognitive therapy or attention 
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training technique as a stand-alone treatment (Knowles et al., 2016; Normann et al., 
2014). In addition, at the longest follow-up measure available, 77.36% of the 
individuals were considered recovered or improved, with the problem being eliminated 
or improvement being maintained during the intervention phase. This result is notable 
inasmuch as the effects of some psychological or psychopharmacological interventions 
tend to reduce or disappear after the withdrawal of treatment (e.g., Hollon, Thase, & 
Markowitz, 2002).  
Regarding our second objective, which pertains to the examination of the efficacy 
of attention training technique as a stand-alone treatment, no significant effect of this 
moderator was found on the outcome measures. This result can be interpreted in two 
ways. First, corroborating the absence of an effect of an attention training technique 
component added to a cognitive behavior therapy program for reducing social phobia 
(McEvoy & Perini, 2009), some components of metacognitive therapy, such as detached 
mindfulness and worry or rumination postponement, may already promote a 
metacognitive mode of processing that interrupts the cognitive attentional syndrome by 
increasing attentional flexibility and executive control. From such a perspective, adding 
an attention training technique module to the package program may provide no 
additional benefit. Second, attention training technique as a stand-alone intervention 
may be in certain cases considered sufficient enough to challenge dysfunctional 
metacognitive beliefs and self-focused attention that perpetuate the cognitive attentional 
syndrome without requiring a more comprehensive metacognitive therapy package. This 
result is of particular interest inasmuch as attention training technique is considered a 
low-cost, easy-to-administer technique that provides an economic advantage compared 
with the full-package therapeutic program (Fergus & Bardeen, 2016). It remains to be 
determined, however, for which cases attention training technique as a stand-alone 
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treatment or metacognitive therapy as a whole treatment package (with or without an 
ATT component) fits best. Given that attention training technique has been shown to 
improve both self-reported mental flexibility and disengagement of attention from 
negative stimuli on a laboratory task (Callinan, Johnson, & Wells, 2015), such 
laboratory tasks (or questionnaires assessing related processes such as the Attention 
Control Scale; Derryberry & Reed, 2002) could tentatively be used to help identify 
individuals who would more likely benefit from this component treatment. 
Regarding other moderators, the results indicated at the study level a significant 
dose-response relationship; that is, the greater the number of sessions, the better the 
outcomes. Although it is difficult to provide an optimal dosage of metacognitive therapy 
or attention training technique sessions, Knowles et al. (2016) and Wells (2009) 
generally considered that changes can be seen after a few weeks when weekly attention 
training technique sessions, guided by the therapist, are associated with daily personal 
practice at home. Nevertheless, Wells (2009) mentioned that more severe cases might 
require more intensive practice of the attention training technique. More generally, 
according to Hansen, Lambert, and Forman (2002), in the clinical trials literature, 
between 57.6% and 67.2% of patients with axis I disorders improve within an average 
of 12.7 sessions. The results also showed that gender moderated the efficacy of 
metacognitive therapy on the outcomes, as women showed worse outcomes than men 
did. Although this result should be interpreted with caution because of the 
overrepresentation of women (80%) in the studies included for the analyses, it is in line 
with the greater incidence and severity of internalizing symptoms (e.g., depression) in 
women than in men. Women may present a more inflexible and excessive cognitive 
attentional syndrome than men do, which in turn makes the treatment less efficacious 
for women. This assumption corroborates previous data showing that gender moderates 
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the link between self-focus attention and negative affect, in that being a woman 
increased the strength of this relationship (Mor & Winquist, 2002). 
At the individual level, the moderator analysis showed that the longer the duration 
of the depression symptoms, the lower the efficacy of metacognitive therapy and/or 
attention training technique. These results indicate that metacognitive therapy and its 
various components might be particularly useful and relevant at an early stage of the 
development of psychopathological symptoms. Indeed, when the cognitive attentional 
syndrome and associated metacognitive beliefs and a nonadaptive self-focus strategy 
have been automatized and become excessively rigid and inflexible, it might be more 
challenging to have the person interrupt the cognitive attentional syndrome triggered by 
negative thoughts based only on metacognitive therapy and/or attention training 
technique interventions. Corroborating previous studies showing that chronicity has 
been associated with more severe psychopathological symptoms (e.g., Visser, van 
Oppen, van Megen, Eikelenboom, & van Balkom, 2014), the results also support that 
the lower the severity of anxiety and depression symptoms at baseline, the better the 
outcomes. Consequently, to maximize the effect of metacognitive therapy and/or 
attention training technique, these interventions might be advantageously proposed at an 
early stage of symptom development, or even in identified at-risk persons, children, or 
adolescents as a way to prevent further development of psychopathological symptoms. 
From this perspective, the metacognitive model has received preliminary empirical 
support in both clinical and nonclinical child or adolescent samples (e.g., Ellis & 
Hudson, 2010). Furthermore, a growing corpus of data supports that metacognitive 
therapy is suitable and efficacious for children or adolescents with GAD or OCD (e.g., 
Esbjørn, Normann, & Reinholdt-Dunne, 2015). 
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Finally, one important implication of the metacognitive model is that it generated 
theoretically based psychological interventions that are effective across emotional 
disorders and can be conceptualized within a transdiagnostic approach of 
psychopathology (Dudley, Kuyken, & Padesky, 2011). The transdiagnostic model 
emerged from the many limitations of the disorder-specific approach (e.g., high 
comorbidity between disorders, intradiagnostic heterogeneity, or poor construct validity 
of psychiatric diagnoses). It postulates that key psychological processes (cognitive, 
affective, motivational, interpersonal) are involved in the onset, perpetuation, and 
recurrence of psychopathological symptoms. In such a theoretical framework, the 
cognitive attentional syndrome, which was found to characterize a wide range of 
emotional disorders, can be viewed as a transdiagnostic pathogenic process that can be 
targeted by specific process-oriented interventions such as the metacognitive therapy 
and/or attention-training technique.  
 
Some limitations to the study must be discussed. First, the methodological quality 
of the single-case studies included in the analyses is, in general, rather poor. In 
particular, all but three studies did not use an experimental design, but rather an A-B 
design, which reduced the opportunity to gather evidence of experimental control over 
the target behaviors as a result of the interventions. However, despite the poor general 
methodological quality regarding the internal validity of the studies included, 
methodological bias scores were not crucially related to the effect sizes. Further single-
case studies should use experimental designs (e.g., a multiple baseline design across 
participants) to increase internal validity. Second, the analyses focused essentially on 
primary outcomes (e.g., various symptoms belonging to a diagnostic category), but not 
on underlying transdiagnosis factors such as measures of metacognitive beliefs or direct 
measures of the cognitive attentional syndrome (which could have been measured by 
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specific self-reports; see Wells, 2009). In most of the studies, measures of 
metacognitive beliefs were used but only administered in the pre- and posttests, thus 
preventing their inclusion in the analyses. Similarly, no included studies used laboratory 
tasks for assessing difficulties in executive control (e.g., mental flexibility) that is 
supposed to underlie the cognitive attentional syndrome. Use of both measures of 
transdiagnostic factors and objective measures of attentional control would have helped 
to further reveal the underlying mechanisms of change in metacognitive therapy and/or 
attention-training technique as a stand-alone treatment.  
 
Conclusions  
To the best of our knowledge, this is the first meta-analysis on single-case studies that 
evaluates the specific effects of a psychological intervention on mental health outcomes 
that used a specific and well-suited data analysis procedure. The current study first 
confirms the large effects of metacognitive therapy and/or attention-training technique 
across various mental health outcomes. Second, it effectively informs evidence-based 
practice in the clinical milieu. Indeed, according to Dattilio (2006), single-case designs 
provide clinicians with more immediacy than do group designs in which the context and 
details of clinical phenomena may be masked or ignored. Crucially, we observed that 
the potential of relying on a meta-analysis of single-case studies to advance knowledge 
in determining evidence-based interventions in clinical psychology research is largely 
under-exploited. This study thus emphasized the relevance of disseminating the use of 
meta-analyses on single-case studies in the field of psychopathological research. Indeed, 
this approach has unique strengths and well complements meta-analyses performed on 
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Diagnosis Strategy intervention Outcomes Design 
Andouz, 2012 13 6 
Obsessive-compulsive 
disorder  
MCT; 14 weekly sessions for 50 min 
OCI-R; Y-BOCS; TFI; MCQ; BDI-II 
AB 
Bailey, 2014 12 4 Hypochondriasis 
 
MCT; 6 to 9 sessions for maximum of 
1 hr 
 
WI; MCHQ; BAI 
AB 




MCT; 8 to 12 sessions for 1 hr 
 
EPDS; HADS-Depression; HADS-Anxiety.  
AB 
Callesen, 2014 10 4 Depression 
 
MCT; 5 to 11 sessions for 1 hr 
BDI-II; MDD-S (rumination time) AB 
Fisher, 2008 12 4 
Obsessive-compulsive 
disorder 
MCT; 12 to 14 sessions for 1 hr BAI; BDI; PI AB 

















MCT; 11 to 13 weekly sessions for 1 
hr 
 
BDI; BAI; PSYRATS delusions; PSYRATS 
voices; worry is harmful; worry is uncontrollable; 














stress) in a cancer 
survivor 
MCT; 7 sessions of 45 to 60 min 
 




Papageorgiou, 1998 8 3 Hypochondriasis 
ATT; 8 to 10 sessions for 30 min 
(including 15 min of ATT) 
Frequency of health worry; illness beliefs; 
frequency of urge to seek reassurance; avoidance 










ATT; 5 to 8 weekly sessions for 30 






Wells, 1990 10 1 Panic disorder 
Therapy 1 (B): ATT, 15 to 18 
sessions for 15 min; 
Therapy 2 (C): standard 
autogenic exercisesa; 12 sessions 
 






8 2 Panic disorder  
ATT; 3 to 4 sessions for 30 min 
(including 10 min of ATT) 
Frequency of panic attacks; BAI; belief ratings 
AB and ABA   
 
 
Wells, 2004 13 6 
Posttraumatic stress 
disorder 
MCT; 8 to 11 sessions for 30 to 60 
min 
DTS; IES; BDI; BAI AB  
Wells et al., 2009 15 4 
Major depressive 
episode 




MCT = metacognitive therapy; ATT = attentional training technique; RoBiNT Scale = Risk of Bias in N-of-1 Trials Scale; OCI-R = Obsessive Compulsive Inventory-
Revised; Y-BOCS = Yale-Brown Obsessive-Compulsive Scale; TFI = Thought Fusion Inventory; MCQ = MetaCognitive Questionnaire; BDI/BDI-II = Beck Depression 
Inventory/Beck Depression Inventory-II; WI = Whiteley Index; MCHQ = Metacognitions about Health Questionnaire; BAI = Beck Anxiety Inventory; EPDS = Edinburgh 
Postnatal Depression Scale; HADS = Hospital Anxiety and Depression Scale; MDD-S = Major Depressive  Disorder Scale; PI = Padua Inventory; PSYRATS = Psychotic 
Symptom Rating Scales; GDS = Geriatric Depression Scale; PQRST = Personal Questionnaire Rapid Scaling Technique; DTS = Davidson Trauma Scale; IES/IES-R = Impact 




Summary of the meta-analyses performed with the d-statistic.  
Statistics All outcomes Anxiety Depression Remaining 
d-statistic (standard error) −1.55 (0.20) −1.41 (0.21) −1.20 (0.25) −1.72 (0.24) 
d-statistic confidence interval (−1.99, −1.08) (−1.93, −0.88) (−1.76, −0.63) (−2.27, −1.17) 
Heterogeneity descriptive statistics τ = 0.57,  
I2 = 81.02%, 
range: −2.58 to −0.60 
τ = 0.20,  
I2 = 14.45%, 
range: −2.78 to −0.66 
τ = 0.51,  
I2 = 55.97%, 
range: −2.91 to −0.28 
τ = 0.65, 
I2 = 76.73%, 
range: −2.74 to −0.67 
Heterogeneity test Q(9) = 61.23, p < .01 Q(6) = 7.72, p = .26 Q(8) = 18.44, p =. 02 Q(8) = 49.23, p < .01 









Figure 1. Flowchart of the study selection process according to the PRISMA statement 







107 records identified through 
database searching 
11 additional records identified 
through other sources 
70 records after duplicates removed 
70 records screened 48 records excluded 
22 full-text articles 
assessed for eligibility 
8 full-text articles 
excluded for various 
reasons: not enough data 
points per phase, 
descriptive case, pre/post 
design, treatment 
embedded in a broader 
program, only the abstract 
available  
14 studies included in 
qualitative synthesis 
d-statistic: 11 studies included in meta-analysis for all outcomes (3 excluded because 
of having fewer than 3 participants ); 7 studies included in meta-analysis for anxiety 
only; 9 studies included in meta-analysis for depression only; 9 studies included in 
meta-analysis for other psychopathological symptoms (“remaining” outcomes). 
Percentage change index: 14 studies included in meta-analysis for all outcomes; 9 
studies included in meta-analysis for anxiety only; 10 studies included in meta-
analysis for depression only; 12 studies included in meta-analysis for the remaining 
outcomes. 









Figure 3. Forest plots for the d-statistic for outcomes measuring depression. 
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